T
This division focuses on developing transformational medicines across key therapeutic areas including Oncology, Immunology, Neuroscience, and Cardiopulmonary. The company leverages rigorous science and data science to advance its product pipeline from discovery through supply. It aims to deliver new therapeutic options to patients globally who are waiting for better treatment outcomes.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This division focuses on developing transformational medicines across key therapeutic areas including Oncology, Immunology, Neuroscience, and Cardiopulmonary. The company leverages rigorous science and data science to advance its product pipeline from discovery through supply. It aims to deliver new therapeutic options to patients globally who are waiting for better treatment outcomes.